Hospital-based epidemiological and clinical characterisation of the malignant transformation of oral leukoplakia in a Chinese population
- PMID: 28276054
- PMCID: PMC9378875
- DOI: 10.1111/idj.12292
Hospital-based epidemiological and clinical characterisation of the malignant transformation of oral leukoplakia in a Chinese population
Abstract
Objective: The aim of this review was to analyse, systematically, hospital-based epidemiological information concerning the malignant transformation rate (MTR) of oral leukoplakia (OL) in a Chinese population, as well as the associated risk factors.
Methods: Four electronic databases were searched for studies dealing with OL and related risk factors, including age, gender, type of lesion, site, and smoking and drinking habits.
Results: The MTR of OL in the hospital-based Chinese population ranged from 4% to 13%, based on the studies analysed. Regarding risk factors, we found that female patients had a higher MTR than male patients, and that patients older than 50 years of age also had a higher MTR. Patients who smoked had a lower MTR, while alcohol consumption seemed to have no association with MTR. Malignant transformation occurred most commonly on the tongue. Regarding lesion type, non-homogeneous OL had a higher MTR, with the granular type having the highest MTR. Our results regarding the epidemiology of OL showed a similar trend to those reported in western populations and provided preliminary epidemiological information on the Chinese population.
Conclusions: Our findings show that female gender, age >50 years and non-homogeneous OL are risk factors for malignant transformation. It is important to develop clinical strategies to educate, diagnose and treat patients with OL and to minimise the MTR of OL.
Keywords: Chinese population; Oral leukoplakia; malignant transformation; risk factor.
© 2017 FDI World Dental Federation.
Similar articles
-
Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patients.BMC Cancer. 2010 Dec 16;10:685. doi: 10.1186/1471-2407-10-685. BMC Cancer. 2010. PMID: 21159209 Free PMC article.
-
Recurrence rates after surgical removal of oral leukoplakia-A prospective longitudinal multi-centre study.PLoS One. 2019 Dec 6;14(12):e0225682. doi: 10.1371/journal.pone.0225682. eCollection 2019. PLoS One. 2019. PMID: 31810078 Free PMC article.
-
Oral leukoplakia in China: a review.Oral Maxillofac Surg. 2010 Dec;14(4):195-202. doi: 10.1007/s10006-010-0214-0. Oral Maxillofac Surg. 2010. PMID: 20369267
-
Oral premalignant lesions: from a clinical perspective.Int J Clin Oncol. 2011 Feb;16(1):5-14. doi: 10.1007/s10147-010-0157-3. Epub 2011 Jan 12. Int J Clin Oncol. 2011. PMID: 21225307 Review.
-
Oral potentially malignant disorders: risk of progression to malignancy.Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 Jun;125(6):612-627. doi: 10.1016/j.oooo.2017.12.011. Epub 2017 Dec 29. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018. PMID: 29396319 Review.
Cited by
-
Human papillomavirus genotypes and p16 expression in oral leukoplakia and squamous cell carcinoma.Int J Clin Exp Pathol. 2019 Mar 1;12(3):1022-1028. eCollection 2019. Int J Clin Exp Pathol. 2019. PMID: 31933914 Free PMC article.
-
Clinical evaluation of photodynamic therapy for oral leukoplakia: a retrospective study of 50 patients.BMC Oral Health. 2024 Jan 3;24(1):9. doi: 10.1186/s12903-023-03791-5. BMC Oral Health. 2024. PMID: 38172857 Free PMC article.
-
Application of 5-aminolevulinic acid-mediated Waterlase-assisted photodynamic therapy in the treatment of oral leukoplakia.Sci Rep. 2022 Jun 7;12(1):9391. doi: 10.1038/s41598-022-13497-3. Sci Rep. 2022. PMID: 35672359 Free PMC article.
-
Transcriptome array screening and verification of oral leukoplakia carcinogenesis-related hypoxia-responsive gene and microRNA.Hua Xi Kou Qiang Yi Xue Za Zhi. 2021 Feb 1;39(1):20-25. doi: 10.7518/hxkq.2021.01.003. Hua Xi Kou Qiang Yi Xue Za Zhi. 2021. PMID: 33723932 Free PMC article. Chinese, English.
-
Photodynamic therapy guidelines for the management of oral leucoplakia.Int J Oral Sci. 2019 Apr 11;11(2):14. doi: 10.1038/s41368-019-0047-0. Int J Oral Sci. 2019. PMID: 30971683 Free PMC article.
References
-
- Dai CA, Fu GC. Oral leukoplakia: etiological analysis, clinical pathology, prevention, therapy. Chin J Stomatol. 1964;10:316–319.
-
- Lan AX, Guan XB, Sun Z. Analysis of risk factors for carcinogenesis of oral leukoplakia. Chin J Stomatol. 2009;44:327–331. - PubMed
-
- Ge HB, Sun Z, Shen SL. A clinical analysis of 211 oral leukoplakia. Beijing J Stomatol. 1999;3:11–12.
-
- Guan XB, Sun Z, Wang JB. Preliminary study on the relationship between smoking, malignant transformation of oral leukoplakia. Beijing J Stomatol. 2001;3:123–124.
-
- Axell T, Pindbord JJ, Smith CJ, et al. Oral white lesions with special reference to precancerous, tobacco- related lesions: conclusions of an international symposium held in Uppsala, Sweden, May 18-21 1994. International Collaborative Group on Oral White Lesions. J Oral Pathol Med. 1996;25:49–54. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources